First Horizon Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

First Horizon Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-755	Closed	-$10K	–	1688
2018 Q4	$10K	Hold	755	–	–	﹤0.01%	1033
2018 Q3	$14K	Hold	755	–	–	﹤0.01%	997
2018 Q2	$19K	Sell	755 -206	-21%	-$4.8K	﹤0.01%	930
2018 Q1	$18K	Hold	961	–	–	﹤0.01%	835
2017 Q4	$23K	Buy	961 +86	+10%	+$1.69K	﹤0.01%	790
2017 Q3	$18K	Buy	875 +305	+54%	+$5.16K	﹤0.01%	831
2017 Q2	$9K	Hold	570	–	–	﹤0.01%	1025
2017 Q1	$8K	Sell	570 -666	-54%	-$9.61K	﹤0.01%	1099
2016 Q4	$34K	Hold	1,236	–	–	﹤0.01%	647
2016 Q3	$34K	Buy	1,236 +33	+3%	+$1.11K	﹤0.01%	641
2016 Q2	$42K	Hold	1,203	–	–	0.01%	559
2016 Q1	$34K	Buy	1,203 +639	+113%	+$18.8K	﹤0.01%	647
2015 Q4	$19K	Buy	564 +324	+135%	+$10.1K	﹤0.01%	753
2015 Q3	$6K	Buy	+240	New	+$10.3K	﹤0.01%	1144

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Horizon Advisors's DPLO Position: Q1 2019 in Review

First Horizon Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 755 shares — an estimated $10K sold.

First Horizon Advisors first reported a position in DPLO in Q3 2015 and held it in 14 quarters. The position peaked at $42K in Q2 2016. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

First Horizon Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
First Horizon Advisors sold 755 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $10K.
First Horizon Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 14 quarters.
First Horizon Advisors's DIPLOMAT PHARMACY, INC. position peaked at $42K in Q2 2016.
150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on First Horizon Advisors's 13F filing for Q1 2019, filed 26 Apr 2019.